Halfdanarson, Thorvardur R.
Mayo Clinic
4 papers on CoChatORCID 0000-0001-8460-1257
Most cited papers
- Verified
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., Shete, S., Hsu, C.-Y., Desai, A., de Lima Lopes, G., et al. (2020) · The Lancet
COVID-19 and healthcare impactsCOVID-19 Clinical Research Studies
Cited by 1,726
- Verified
BACCI: A phase II randomized, double-blind, multicenter, placebo-controlled study of capecitabine (C) bevacizumab (B) plus atezolizumab (A) or placebo (P) in refractory metastatic colorectal cancer (mCRC): An ACCRU network study
Mettu, N. B., Twohy, E., Ou, F.-S., Halfdanarson, T. R., Lenz, H. J., Breakstone, R., Boland, P. M., Crysler, O., Wu, C., Grothey, A., et al. (2019) · Annals of Oncology
Colorectal Cancer Treatments and StudiesCancer Immunotherapy and Biomarkers
Cited by 72
- Verified
Borderline resectable and locally advanced pancreatic cancer: FDG PET/MRI and CT tumor metrics for assessment of pathologic response to neoadjuvant therapy and prediction of survival
Panda, A., Garg, I., Truty, M. J., Kline, T. L., Johnson, M. P., Ehman, E. C., Suman, G., Anaam, D. A., Kemp, B. J., Johnson, G. B., et al. (2021) · American Journal of Roentgenology
Pancreatic and Hepatic Oncology ResearchMedical Imaging Techniques and Applications
Cited by 71
- Verified
Association of a remote patient monitoring (RPM) program with reduced hospitalizations in cancer patients with COVID-19
Pritchett, J. C., Borah, B. J., Desai, A. P., Xie, Z., Saliba, A. N., Leventakos, K., Coffey, J. D., Pearson, K. K., Speicher, L. L., Orenstein, R., et al. (2021) · JCO Oncology Practice
Telemedicine and Telehealth ImplementationCOVID-19 and healthcare impacts
Cited by 32
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free